Manufacturer record
Sarwal Laboratory: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Sarwal Laboratory (Himachal Pradesh) was declared Not of Standard Quality in September 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T-5479, IM-OKTM (Levocetirizine Hydrochloride Tablets IP) (exp Aug 2023). RDTL Guwahati (state lab) found it not of standard quality: Dissolution. Listed in the September 2022 alert.
Records by type
1 record linked to Sarwal Laboratory in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| IM-OKTM (Levocetirizine Hydrochloride Tablets IP) | Batch T-5479Mfg Sep 2021 · Exp Aug 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.